Zai Lab Limited insider, Joshua L. Smiley, sold 1,988 shares at $15.67 on April 4th.

Insider Joshua L. Smiley of Zai Lab Limited sold 1,988 shares of the company's stock at an average price of $15.67 on April 4th, bringing his total shares to 28,684 valued at $449,478. Zai Lab, a biopharmaceutical company, focuses on developing therapies for oncology, autoimmune disorders, infectious diseases, and neuroscience. The company has a market cap of $1.53bn, a negative net margin of 125.46%, and commercial products including Zejula, Optune, NUZYRA, Qinlock, and VYVGART.

April 06, 2024
4 Articles